Allergan Must Face Generic Drug Price-Fixing Claims
By Bill Wichert ( September 30, 2021, 9:50 PM EDT) -- A New Jersey federal judge Thursday nixed Allergan's bid to toss a generic drug price-fixing lawsuit on the grounds that funds affiliated with TIAA-CREF were too late in filing their claims since similar antitrust actions based on related government investigations were filed more than a year earlier....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.